The ICCAM platform study is funded by the Medical Research Council (MRC) of the United Kingdom. ICCAM is a clinical brain imaging study which will investigate medicines that may help in preventing alcohol and drug relapse. The study will carry out research in people who have recently stopped using alcohol, cocaine or heroin.
The ICCAM platform study is being conducted in Cambridge, London and Manchester. If you are eligible and would like to take part, please select one of the following locations that is nearest to you:
By taking part in the ICCAM study, you will be:
This project is funded by the Medical Research Council (MRC) and has been approved by the West London Research Ethics Committee. REC reference 11/H0707/9.
ICCAM is a collaboration between Imperial College London and the Universities of Cambridge and Manchester. This project is funded by the Medical Research Council.
ICCAM is a collaboration between the Universities of Cambridge | London | Manchester | Contact details
The University of Manchester, Royal Charter Number: RC000797
This website will look much better in a web browser that supports web standards, but it is accessible to any browser or Internet device.